期刊文献+

生物节律调控关键基因遗传变异与乳腺癌患病风险的相关性 被引量:5

Association of genetic variantions of circadian clock genes and risk of breast cancer
原文传递
导出
摘要 目的研究生物节律调控关键基因Clock和Per2的遗传变异与乳腺癌发病风险的关系。方法采用病例一对照研究,使用TaqMan荧光定量PCR法检测406例乳腺癌患者和412例健康对照者位于Clock基因(~2070062)和Per2基因(rs2304672、rs2304669、rs934945)的4个位点的基因多“态性,采用非条件~gistic回归模型分析不同基因型或等位基因与乳腺癌发病风险的关系。结果携带rs2304669-TT基因型者发生乳腺癌的风险是携带rs2304669一CC+CT基因型者的2.33倍(P=0.001)。单体型分析的结果也显示,所有含有rs2304669-T等位基因的单体型均可增加乳腺癌的发病风险。而另外3个位点未发现与乳腺癌的发病相关。结论位于Per2基因上的rs2304669位点可能与乳腺癌的发病风险相关;生物节律调控关键基因Per2的遗传变异会增加乳腺癌的发病风险,可能可以作为乳腺癌易感性的重要分子生物标志物。 Objective To investigate the relationship between genetic variantions of circadian clock genes and risk of breast cancer. Methods A case-control study including 406 breast cancer patients and 412 controls was conducted and genes Clock (rs2070062) and Per2 ( rs2304672, rs2304669, rs934945 ) were genotyped by TaqMan real-time PCR. Unconditional logistic regression model was used to analyze the association between the genetic polymorphisms and breast cancer. Results Individuals with the rs2304669- TT genotype showed significantly increased breast cancer risk with the OR of 2.33 when compared with the individuals with rs2304669-CC and CT genotypes (P = 0.001 ). In addition, the three haplotypes containing the risk T allele of rs2304669 were identified to be associated with increased breast cancer risk. However, it was found that rs2304672, rs2070062 and rs934945 polymorphisms were not related with breast cancer risk. Conclusions The locus rs2304669 on Per2 gene is associated with breast cancer risk. Genetic variation of circadian clock genes may increase the susceptibility to breast cancer. Therefore, it may become an important biomarker of susceptibility to breast cancer.
出处 《中华肿瘤杂志》 CAS CSCD 北大核心 2013年第3期236-239,共4页 Chinese Journal of Oncology
基金 吴阶平医学基金会临床科研专项资助基金(320.670010006) 杨森科学研究委员会中国分会基金
关键词 乳腺肿瘤 变异(遗传学) CLOCK基因 Per2基因 Breast neoplasms Variantion (genetic) Clock gene Per2 gene
  • 相关文献

参考文献17

  • 1Jemal A, Bray F, Center MM, et al. Global cancer statistics. CA Cancer J Clin, 2011,61:69-90.
  • 2杨玲,李连弟,陈育德,D.M.Parkin.中国乳腺癌发病死亡趋势的估计与预测[J].中华肿瘤杂志,2006,28(6):438-440. 被引量:278
  • 3陈万青.2004-2005年中国恶性肿瘤发病与死亡的估计[J].中华肿瘤杂志,2009,31(9):664-668. 被引量:136
  • 4Easton DF, Pooley KA, Dunning AM, et al. Genome-wide association study identifies novel breast cancer susceptibility loci. Nature, 2007, 447 : 1087-1093.
  • 5Turnbull C, Ahmed S, Morrison J, et al. Genome-wide association study identifies five new breast cancer susceptibility loci. Nat Genet, 2010, 42:504-507.
  • 6Matsuo T, Yamaguehi S, Mitsui S, et al. Control mechanism of the circadian clock for timing of cell division in vivo. Science, 2003, 302:255-259.
  • 7Gery S, Komatsu N, Baldjyan L, et al. The circadian gene perl plays an important role in cell growth and DNA damage control in human cancer cells. Mol Cell, 2006, 22:375-382.
  • 8Baker FC, Driver HS. Circadian rhythms, sleep, and the menstrual cycle. Sleep Meal, 2007, 8:613-622.
  • 9Hirayama J, Sassone-Corsi P. Structural and functional features of transcription factors controlling the circadian clock. Curt Opin Genet Dev, 2005, 15:548-556.
  • 10Chen ST, Choo KB, Hou MF, et al. Deregulated expression of the PER1, PER2, and PER3 genes in breast cancers. Carcinogenesis, 2005, 26 : 1241-1246.

二级参考文献16

  • 1李连弟,鲁凤珠.1990—1992年中国恶性肿瘤死亡流行分布情况分析[J].中华肿瘤杂志,1996,18(6):403-407. 被引量:226
  • 2李连弟,鲁凤珠,张思维,牧人,孙秀娣,皇甫小梅,孙杰,周有尚,欧阳宁慧,饶克勤,陈育德,孙爱明,薛志福,夏毅.中国恶性肿瘤死亡率20年变化趋势和近期预测分析[J].中华肿瘤杂志,1997,19(1):3-9. 被引量:869
  • 3全国肿瘤防治研究办公室,全国肿瘤登记中心,卫生部疾病预防控制局.中国肿瘤登记年报(2004).北京:中国协和医科大学出版社,2008:10.
  • 4中华人民共和国卫生部.全国第三次死因回顾抽样调查报告.北京:中国协和医科大学出版社,2008:10.
  • 5Verdecchia A, De Angelis R, Francisci S, et al. Methodology for estimation of cancer incidence, survival and prevalence in Italian regions. Tumori, 2007, 93:337-344.
  • 6Yang L, Parkin DM, Ferlay J, et al. Estimates of cancer incidence in China for 2000 and projections for 2005. Cancer Epidemiol Biomarkers Prev, 2005, 14:243-250.
  • 7全国肿瘤防治研究办公室 卫生部卫生统计信息中心.中国恶性肿瘤危险因素研究[M].北京:中国协和医科大学出版社,2003..
  • 8Parkin DM, Bray F, Ferlay J, Pisani P. Global cancer statistics,2002. CA Cancer J Clin, 2005, 55:74-108.
  • 9Parkin DM, Whelan SL, Ferlay J, et al. Cancer in five continents.Vol Ⅷ. IARC scientific publication No. 155. Lyon: IARC Press,2002. 212-231.
  • 10Kim HJ, Fay MP, Feuer EJ, et al. Permutation tests for joinpoint regression with applications to cancer rates. Stat Med, 2000, 19 :335 -351.

共引文献409

同被引文献44

引证文献5

二级引证文献17

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部